1. Buchberger W, DeKoekkoek-Doll P, Springer P, Obrist P, Dünser M. Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol. 1999. 173:921–927.
Article
2. Poplack SP, Tosteson AN, Grove MR, Wells WA, Carney PA. Mammography in 53,803 women from the New Hampshire mammography network. Radiology. 2000. 217:832–840.
Article
3. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008. 299:2151–2163.
Article
4. Houssami N, Lord SJ, Ciatto S. Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography. Med J Aust. 2009. 190:493–497.
Article
5. Obenauer S, Hermann KP, Grabbe E. Applications and literature review of the BI-RADS classification. Eur Radiol. 2005. 15:1027–1036.
Article
6. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology. 2006. 239:385–391.
Article
7. Mendelson E, Baum J, Berg W, Merritt C, Rubin E. Ultrasound. Breast Imaging Reporting and Data System (BI-RADS). 2003. 4th ed. Reston, VA: American College of Radiology.
8. Kim EK, Ko KH, Oh KK, Kwak JY, You JK, Kim MJ, et al. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography. AJR Am J Roentgenol. 2008. 190:1209–1215.
Article
9. Yoon JH, Kim MJ, Moon HJ, Kwak JY, Kim EK. Subcategorization of ultrasonographic BI-RADS category 4: positive predictive value and clinical factors affecting it. Ultrasound Med Biol. 2011. 37:693–699.
Article
10. ACR BI-RADS, breast imaging and reporting data systems: breast imaging atlas; mammography, breast ultrasound, magnetic resonance imaging. 2003. Reston, VA: American College of Radiology.
11. Raza S, Chikarmane SA, Neilsen SS, Zorn LM, Birdwell RL. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome. Radiology. 2008. 248:773–781.
Article
12. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995. 196:123–134.
Article
13. Baek SE, Kim MJ, Kim EK, Youk JH, Lee HJ, Son EJ. Effect of clinical information on diagnostic performance in breast sonography. J Ultrasound Med. 2009. 28:1349–1356.
Article
14. Lee HJ, Kim EK, Kim MJ, Youk JH, Lee JY, Kang DR, et al. Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound. Eur J Radiol. 2008. 65:293–298.
Article
15. Park CS, Lee JH, Yim HW, Kang BJ, Kim HS, Jung JI, et al. Observer agreement using the ACR Breast Imaging Reporting and Data System (BI-RADS)-ultrasound, First Edition (2003). Korean J Radiol. 2007. 8:397–402.
Article
16. You JK, Kim EK, Kwak JY, Kim MJ, Oh KK, Park BW, et al. Focal fibrosis of the breast diagnosed by a sonographically guided core biopsy of nonpalpable lesions: imaging findings and clinical relevance. J Ultrasound Med. 2005. 24:1377–1384.
Article
17. Stavros A. Breast Ultrasound. 2004. Philadelphia: Lippincott Williams & Wilkins.
18. Han BK, Choe YH, Park JM, Moon WK, Ko YH, Yang JH, et al. Granulomatous mastitis: mammographic and sonographic appearances. AJR Am J Roentgenol. 1999. 173:317–320.
Article
19. Sweeney DJ, Wylie EJ. Mammographic appearances of mammary duct ectasia that mimic carcinoma in a screening programme. Australas Radiol. 1995. 39:18–23.
Article
20. Schnitt SJ, Collins LC. Biopsy Interpretation of the Breast. 2009. 1st ed. New York: Lippincott Williams & Wilkins.
21. Mitnick JS, Vazquez MF, Harris MN, Roses DF. Differentiation of radial scar from scirrhous carcinoma of the breast: mammographic-pathologic correlation. Radiology. 1989. 173:697–700.
Article
22. Adler DD, Helvie MA, Oberman HA, Ikeda DM, Bhan AO. Radial sclerosing lesion of the breast: mammographic features. Radiology. 1990. 176:737–740.
Article
23. Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology. 2006. 48:683–691.
Article
24. Ichihara S, Fujimoto T, Hashimoto K, Moritani S, Hasegawa M, Yokoi T. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast. Pathol Int. 2007. 57:126–132.
Article
25. Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, et al. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast. J Clin Pathol. 2007. 60:315–320.
Article
26. Grin A, O'Malley FP, Mulligan AM. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. Am J Surg Pathol. 2009. 33:1615–1623.
Article
27. Resetkova E, Hoda SA. "Ossifying-type" mammary calcifications. Arch Pathol Lab Med. 2002. 126:995–996.
Article
28. Hoda SA, Gopalan A. Mammary calcifications of the ossifying type. Breast J. 2003. 9:129–130.
Article